	US 12,291,515 B2
	Pyrrolidine derivative and use thereof
Zheming Wang, Hangzhou (CN); and Hao Tan, Hangzhou (CN)
Assigned to Zheming Wang, Hangzhou (CN); and Rushi Biotech (Hangzhou) Co., Ltd, Hangzhou (CN)
Filed by Zheming Wang, Hangzhou (CN); and Rushi Biotech (Hangzhou) Co., Ltd, Hangzhou (CN)
Filed on Dec. 13, 2022, as Appl. No. 18/080,732.
Claims priority of application No. 202111595168.8 (CN), filed on Dec. 22, 2021.
Prior Publication US 2023/0192651 A1, Jun. 22, 2023
Int. Cl. C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01)

CPC C07D 401/12 (2013.01) [C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01)]

1 Claim

1. A pyrrolidine derivative or a pharmaceutically acceptable salt thereof, wherein the pyrrolidine derivative has a structure selected from the group consisting of: